1Schwartz RS, Berkman EM, Silberstein LE. Autoimmune hemolytic anemias. In: Hoffman RH, Benz EJ Jr, Shattil S J, et al , eds. Hematology: Basic Principles and Practice, ed 3. Philadelphia, PA : Churchill Livingstone, 2000:611-630.
2Fries LF, Brickman CM, Frank MM. Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocortieoid therapy. J Immuno, 1983 ; 131 : 1240-1245.
4Eichner ER. Splenic function : Normal, too much and too little. Am J Med, 1979 ;66:311-320.
5Newland A, Provan D. Preventing severe infection after splenectomy. Bdt Med J, 2005 ;331:20-7.
6Centers for Disease Control and Prevention: Recommended adult immunization schedule-United States, 2003-2004. MMWR 2003; 52:965-969.
7Dacie JV. The Haemolytic Anaemias. The Autoimmune Haemolytic Anaemias, vol. 3. New York: Churchill Livingstone, 1992. 12.
8Moyo VM, Smith D. , Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose eyclopbosphamidd, e for refractory autoimmune hemolytic anemia. Blood ,2002 ; 100 :704-746.
9Amy Sobota, MDResponse to Mercaptopurine for Refractory Autolmmune Cytopenias in Children. Pediatr Blood Cancer, 2009 ;52:80-84.
10milia C, Messora C, Longo G, Bertesi M. Long-term salvage treatment by cyclosporine in refractory autoimmune haematological disorders. Br J Haematol, 1996 ;93:341-344,.
8Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update [ J ]. Expert Rev Hematol, 2011,4 : 607-618.
9Valent P, Lechner K. Diagnosis and treatment of autoimmune hae- molytic anaemias in adults: a clinical review [ J ]. Wien Klin Wochenschr,2008,120 : 136-151.
10Berentsen S, Sundic T, Hervig T, et al. Autoimmune hemolytic a- nemia [ J ]. Tidsskr Nor Laegeforen ,2009,129:2226 -2231.